Dr. Kent Crowley

Co-Founder & Director, Research & Development, Trokie CA Inc.

A highly trained pharmaceutical executive and consultant, Dr. Kenton Crowley has over 30 years experience in the pharmaceutical industry and clinical medicine. He obtained his Doctor of Pharmacy from the University of California, San Francisco; completed an ASHP Accredited Residency with Kaiser Permanente. He is an Advanced Fellow and Diplomat of the American Academy of Anti-Aging Medicine. At Silver State Trading, a 40,000 sq.ft. Clean Green cultivation and production facility in Sparks, NV, Dr. Kent is the Director of Research and Development, overseeing the production of Trokie® products and future patents. Dr. Crowley is the founder and creator of Trokie®, a patented buccal delivery system for cannabis (U.S. Patent No.: 9,675,656 B2) and runs the California operations for Trokie California Inc.

Dr. Crowley developed and patented two other U.S. patents for the treatment of neuropathic pain prior to entering the cannabis industry. Dr. Crowley serves as the Chief Medical Officer of the Palliative Care Corp, a clinic in Huntington Beach, CA that has treated over 2000 patients incorporating cannabis in disease state treatment and symptoms management, whether as a primary treatment or complementary to traditional and/or other modalities.

He is a member of the Society of Cannabis Clinicians and on the Research Subcommittee, a member of the International Cannabinoid Research Society and a member of the Integrative Think Tank for University of California’s, Center for the Study of Cannabis. An inventor, drug developer, professor, author, clinician and entrepreneur, Dr. Crowley continues to offer cutting edge approaches to solving the problems faced by established as well as emerging new business models in medicine and the pharmaceutical industry.

Matthew Greene

New York, NY, USA
CEO & Founder, Edible Science, LLC

Matt Greene has spent his entire career in the marketing, advertising and AdTech industry. His fascination with technology began in 1987 while working with his client Steve Jobs in developing the launch strategies for NeXT Computers. Starting in 1998, Matt pioneered online advertising and supporting technologies for the digital ad agency he founded, Blue Ribbon Digital, where his team drove innovation across all aspects of digital media - from Search to Mobile and Video, his agency measurably generated over $2BB in revenues for their Fortune 100 clients. In this capacity, Matt has spoken at leading conferences such as AdTech, iMedia Summits and the Googleplex in Mountain View, CA. Starting in 2015, Matt re-focused his energies on the burgeoning cannabis industry knowing that the need for innovation in technologies to support the industry would be mandatory. With his his new company, Edible Sciences, he and his team on concentrating their energies in solving the #1 problem facing the edibles sector: Dosing Accuracy. He will be speaking at Binghampton University's TIER Talks in SEPT '17 on technology innovations occurring in the cannabis ancillary space.
Close

Brett Finkelstein

Boca Raton, FL
Managing Director, Phyto Partners LP

Brett is an experienced executive, venture capital and private equity investor and advisor. He has partnered with, worked with and developed key relationships with numerous premier private equity, investment banks, and venture capital companies. As one of the founders of Phyto Partners LP, Brett’s fundamental ambition for the company’s stakeholders is to creatively apply his unique resources of extensive operating skills, certainty to close, access to capital, extensive network of resources and relentless pursuit of excellence to facilitate a more super-charged evolution for enterprises we fund, launch, and maintain activist roles in. For the powerhouse companies we invest in, advise, and or buy we will be providing more investment value and a comfort level for our financial capital partners, as well as our portfolio companies that join us. Phyto Partners LP was profiled in Forbes as one of the leaders in the cannabis industry. Phyto has invested in half of what CB insights profiled as the trailblazers of 2017. 
Close